Stock Taper 
CASDIN CAPITAL, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Relay Therapeutics, Inc. | RLAY | 16.04M | $300.02M |
 BioLife Solutions, Inc. | BLFS | 4.66M | $131.46M |
 GeneDx Holdings Corp. | WGS | 3.71M | $254.5M |
 Prime Medicine, Inc. | PRME | 3.17M | $11.69M |
 Revolution Medicines, Inc. | RVMD | 2.58M | $482.68M |
 Denali Therapeutics Inc. | DNLI | 2.04M | $52.6M |
 Beam Therapeutics Inc. | BEAM | 1.35M | $46.33M |
 10x Genomics, Inc. | TXG | 1.05M | $40.26M |
 Absci Corporation | ABSI | 973.26K | $11.28M |
 Hims & Hers Health, Inc. | HIMS | 700K | $24.27M |
 Scholar Rock Holding Corporation | SRRK | 665K | $36.58M |
 Applied Aerospace & Defense, Inc. | AADX | 645.69K | $17.67M |
 Septerna Inc | SEPN | 553.27K | $18.53M |
 Illumina, Inc. | ILMN | 530K | $93.19M |
 GRAIL Inc. | GRAL | 480K | $32.77M |
 Sarepta Therapeutics, Inc. | SRPT | 470K | $8.45M |
 Editas Medicine, Inc. | EDIT | 445K | $1.44M |
 Intellia Therapeutics, Inc. | NTLA | 355K | $6.01M |
 Veracyte, Inc. | VCYT | 276.31K | $16.23M |
 Monte Rosa Therapeutics, Inc. | GLUE | 186.01K | $4.5M |